Parse Biosciences has announced a significant milestone in their funding journey, securing a total of $50 million through a Series C equity raise and a debt facility. This round of financing was led by Soleus Capital and witnessed participation from several new and existing investors such as Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen […]
Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments for fibrosis and cancer. Led by Soleus Capital and co-led by Eir Ventures, the funding round is said to strengthen the existing cash balance of Galecto, extending its cash runway into late 2022. The financing round saw […]
